tweetup-jacek-nov2016-ok-mas-oscurook

Access to Medicines: join us in the debate!

The role of generic, biosimilar and value added medicines in increasing access to innovative treatment

CONNECT BY USING THE HASHTAG
#ASKJACEKGLINKA

The Value Added Medicines Group Highlights the Importance of 3 October 2016 The Value Added Medicines Group a sector group of Medicines…
Generic, Biosimilar and Value Added Medicines Industry… 9 June 2016 During the next two days, the key pharmaceutical industry leaders…
EGA becomes Medicines for Europe 10 March 2016 The European Generic and Biosimilar Medicines Association is now Medicines…
Generic and Biosimilar Medicines Essential for Italian… 8 January 2016 Brussels - Generic and biosimilar medicines represent an essential opportunity to…